New antiretroviral agents clinic first clinical trial zidovudine ACT fall use agent treatment human immunodeficiency virus HIV infection recent report HIV resistance long-term AZT therapy sense urgency development additional agents use combination AZT infection Several new agents various stages preclinical clinical evaluation dideoxycytidine dideoxyinosine dideoxydidehydrothymidine azidouridine foscarnet inhibit viral DNA synthesis inhibition reverse transcriptase Other useful agents different stages infection Soluble example soluble form receptor HIV cells castanospermine new class compounds maturation process viral glycoprotein potent toxic analogue latter agent N-butyl-deoxynojirimycin phase 